Join
Live feed
·
INSIDERFilingvia Quantisnow
Tarsus Pharmaceuticals Inc. logo

Chief Medical Officer Lin Elizabeth Yeu converted options into 6,819 shares and sold $165,201 worth of shares (2,078 units at $79.50), increasing direct ownership by 28% to 21,941 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TARS (Tarsus Pharmaceuticals Inc.) and more on Quantisnow.